Conolidine’s analgesic results stem from its conversation with non-opioid pain pathways. Unlike opioids, which bind to µ-opioid receptors in the central nervous method, conolidine modulates alternate molecular targets. A Science Improvements examine observed that conolidine interacts With all the atypical chemokine receptor ACKR3/CXCR7, which re